Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Overview
- Polymeric drug delivery systems
- Polysaccharides
- What is drug delivery?
- Drug delivery systems
- Routes of drug delivery
- 4Ds approach to select drug delivery systems
- Cancer
- Challenges in cancer treatment
- Timeline of turning points
- Evolution of cancer treatment
- Drug delivery systems for cancer treatment
- Oral drug delivery systems
- Orally targeted drug delivery
- Transdermal drug delivery systems
- Improved transdermal drug delivery systems
- Implantable drug delivery systems
- Implantable systems in cancer therapeutics
- Advanced drug delivery systems
- Nanoparticles
- Polymeric nanoparticles
- Loading of anticancer drugs in nanoparticles
- Polymeric micelles
- Functions of polymeric micelles
- Solid Lipid Nanoparticles (SLNs)
- Dendrimers
- Liposomes
- Functional classification of liposomes
- Niosomes
- Magnetic nanoparticles (MNPs)
- Gold nanoparticles
- Mesoporous Silica Nanoparticles (MSNs)
- Carbon Nanotubes (CNTs)
- Stimuli-responsive nanocarriers
- Nanotoxicology
- Concluding remarks
- Acknowledgements
Topics Covered
- Cancer Therapeutics
- Drug Delivery Mechanisms
- Drug Development
- Liposomes
- Nanoparticles
- Nanotechnology
- Nanotoxicology
- Niosomes
- Dendrimers
- Micelles
- Routes of Drug Delivery
Talk Citation
Aminabhavi, T. (2021, July 28). Drug delivery for cancer therapeutics [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/NQCZ4792.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Tejraj Aminabhavi has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: Drug Delivery
Transcript
Please wait while the transcript is being prepared...
0:00
This is Professor T. M. Aminabhavi,
I'm the Director of Research at the College of Pharmacy, Dharwad, India.
I obtained my PhD from the University of Texas in Austin, USA.
In the past 35 to 40 years I have been able to publish 800 research papers, and three US patents.
I'm presently the editor of The Chemical Engineering Journal.
My expertise is in the area of polymer development for drug delivery,
membrane science, and wastewater treatment.
0:36
In this talk, I'm going to cover different aspects of polymers.
What type of polymers are useful with regards to their drug delivery applications.
Mainly for drug delivery applications we need to look at smaller sizes,
as small as nanoparticle size.
We need to develop these systems using
polymers of different kinds, and that will be used in cancer therapy.
I will cover, in this talk, drug targeting to cancer cells.
We will talk about passive and active targeting.
Then I will talk about ligand-receptor interactions.
I will cover several biopolymers, that is, naturally-occurring polymers.
Most of the polymers that we will be covering are poly(lactide-co-glycolide), polylactide, polycaprolactone, alginates
(namely sodium alginate), chitosan, hyaluronic acid,
solid lipid nanoparticles, and many other polymers such as micelles,
dendrimers, and co-polymers, and so on.